{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:42:24Z","timestamp":1791999744525,"version":"4.4.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2020.00077","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T11:13:14Z","timestamp":1588245194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial Hypertension"],"prefix":"10.3389","volume":"7","author":[{"given":"Katharine R.","family":"Clapham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin B.","family":"Highland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim H.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1378\/chest.15-0300","article-title":"Five-Year outcomes of patients enrolled in the reveal registry","volume":"148","author":"Farber","year":"2015","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1378\/chest.123.2.344","article-title":"Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis","volume":"123","author":"Kawut","year":"2003","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/CIRCHEARTFAILURE.112.000008","article-title":"Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension","volume":"6","author":"Tedford","year":"2013","journal-title":"Circ Heart Fail."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1161\/CIRCULATIONAHA.116.022082","article-title":"Right ventricular functional reserve in pulmonary arterial hypertension","volume":"133","author":"Hsu","year":"2016","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1161\/CIRCULATIONAHA.117.033147","article-title":"Right ventricular myofilament functional differences in humans with systemic sclerosis-associated versus idiopathic pulmonary arterial hypertension","volume":"137","author":"Hsu","year":"2018","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.healun.2015.12.028","article-title":"Right atrial pressure\/pulmonary artery wedge pressure ratio: a more specific predictor of survival in pulmonary arterial hypertension","volume":"35","author":"Fares","year":"2016","journal-title":"J Heart Lung Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1183\/09031936.06.00044406","article-title":"Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil","volume":"28","author":"Barst","year":"2006","journal-title":"Eur Respir J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00005344-200302000-00019","article-title":"Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension","volume":"41","author":"McLaughlin","year":"2003","journal-title":"J Cardiovasc Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.healun.2011.03.011","article-title":"Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials","volume":"30","author":"Benza","year":"2011","journal-title":"J Heart Lung Transplant."},{"key":"B17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.healun.2013.03.004","article-title":"Right ventricular stroke work index as a negative predictor of mortality and initial hospital stay after lung transplantation","volume":"32","author":"Armstrong","year":"2013","journal-title":"J Heart Lung Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10877-010-9234-4","article-title":"The units of measurement of the ventricular stroke work: a review study","volume":"24","author":"Schramm","year":"2010","journal-title":"J Clin Monit Comput."},{"key":"B19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ccd.23309","article-title":"The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction","volume":"80","author":"Korabathina","year":"2012","journal-title":"Catheter Cardiovasc Interv."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/rccm.201507-1456OC","article-title":"Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension","volume":"192","author":"Rhee","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1164\/rccm.201507-1398OC","article-title":"Ambrisentan and tadalafil up-front combination therapy in scleroderma-associated pulmonary arterial hypertension","volume":"192","author":"Hassoun","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1701436","DOI":"10.1183\/1393003.congress-2017.OA1506","article-title":"Right ventricular strain differences between idiopathic and systemic sclerosis Pulmonary Hypertension","volume":"50","author":"Mukherjee","year":"2017","journal-title":"Eur Respir J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1164\/rccm.200912-1820OC","article-title":"Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension","volume":"182","author":"Campo","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1800678","DOI":"10.1183\/13993003.00678-2018","article-title":"Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension","volume":"52","author":"Weatherald","year":"2018","journal-title":"Eur Respir J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.jacc.2008.03.009","article-title":"The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates","volume":"51","author":"Matthews","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1378\/chest.84.6.719","article-title":"Right ventricular stroke-work. An index of distribution of pulmonary perfusion in acute respiratory failure","volume":"84","author":"Her","year":"1983","journal-title":"Chest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/01.CIR.9.5.706","article-title":"Ventricular function. I. Starling's law of the heart studied by means of simultaneous right and left ventricular function curves in the dog","volume":"9","author":"Sarnoff","year":"1954","journal-title":"Circulation."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T11:13:16Z","timestamp":1588245196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2020.00077"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.00077","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"77"}}